Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer

Published:2022-07-03 Issue:3 Volume:27 Page:289-300
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Bote Helena¹²,Mesas Andrés³,Baena Javier¹²,Herrera Mercedes¹²,Paz-Ares Luis¹²⁴⁵

Affiliation:

1. Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain

2. H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octbure (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain

3. Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain

4. CIBERONC, Madrid, Spain

5. Department of Medicine, Complutense University, Madrid, Spain

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2022.2113377

Reference83 articles.

1. Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

2. Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review

3. Preexisting Autoimmune Disease: Implications for Immune Checkpoint Inhibitor Therapy in Solid Tumors

4. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies;Oncology and Therapy;2024-01-30

2. Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway;Journal of Ethnopharmacology;2024-01

3. Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors;Oncology Letters;2023-08-23

4. Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer;International Journal of General Medicine;2023-03

5. Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer;Frontiers in Pharmacology;2023-02-15